Detalhe da pesquisa
1.
Evaluation of the association of area-level socioeconomic deprivation and breast cancer recurrence by oestrogen receptor subtypes in Scotland.
Breast Cancer Res
; 25(1): 106, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37784154
2.
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer Treatment.
Oncologist
; 28(3): e145-e155, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719033
3.
Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009-2016: a cross-sectional study.
Breast Cancer Res Treat
; 196(2): 379-387, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36116093
4.
Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype.
Breast Cancer Res Treat
; 194(2): 463-473, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35648299
5.
Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data.
Br J Cancer
; 123(5): 852-859, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32555534
6.
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Lancet
; 393(10191): 2599-2612, 2019 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31178152
7.
Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer: A retrospective cohort study.
PLoS Med
; 16(12): e1003006, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31891574
8.
Toward a Framework for Outcome-Based Analytical Performance Specifications: A Methodology Review of Indirect Methods for Evaluating the Impact of Measurement Uncertainty on Clinical Outcomes.
Clin Chem
; 65(11): 1363-1374, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444309
9.
Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer.
Cost Eff Resour Alloc
; 17: 5, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867655
10.
Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data.
Br J Cancer
; 119(7): 808-814, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30220705
11.
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis.
Oncologist
; 22(6): 694-699, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28592621
12.
Secondary-care costs associated with lung cancer diagnosed at emergency hospitalisation in the United Kingdom.
Thorax
; 72(10): 950-952, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28137919
13.
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial.
Value Health
; 20(10): 1311-1318, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29241890
14.
The economic burden of cancer in the UK: a study of survivors treated with curative intent.
Psychooncology
; 25(1): 77-83, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26087260
15.
Can D-Dimer Measurement Reduce the Frequency of Radiological Assessment in Patients Receiving Palliative Imatinib for Gastrointestinal Stromal Tumor (GIST)?
Cancer Invest
; 33(8): 347-53, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26135352
16.
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial.
Lancet Oncol
; 14(10): 933-42, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23932548
17.
Variation in colorectal cancer treatment and outcomes in Scotland: real world evidence from national linked administrative health data.
Int J Popul Data Sci
; 9(1): 2179, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38476269
18.
Variation in hospital cost trajectories at the end of life by age, multimorbidity and cancer type.
Int J Popul Data Sci
; 8(1): 1768, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721848
19.
Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma-A Post-hoc Analysis of the GO2 Trial.
Cancers (Basel)
; 15(9)2023 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174057
20.
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors.
JAMA Netw Open
; 6(2): e230490, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821111